Breaking News

Sirona Biochem Names CEO

October 12, 2012

Belenkie brings extensive business and healthcare experience

Neil Belenkie has been appointed chief executive officer of Sirona Biochem Corp. Dr. Howard Verrico will remain chairman of the board.
“Neil Belenkie brings to Sirona Biochem the experience, determination and network we need to accelerate growth,” said Dr. Dr. Verrico, Sirona Biochem’s founder and chairman of the board. “Sirona Biochem’s programs have matured from scientific concepts to compounds showing commercial potential.  It’s the right time to welcome Neil Belenkie’s leadership to Sirona Biochem to propel these programs forward.”
Neil Belenkie, a winner of Business in Vancouver Magazine’s Top 40 Under 40, brings his significant healthcare experience to Sirona Biochem. Mr. Belenkie’s career in life sciences includes leadership roles in sales, market research, marketing, and medical education. He is the founder of strategic management consulting company GrowthPoint Group, which provides business solutions for long-term growth. His life sciences background includes leadership roles at Ortho Biotech and Hoffman LaRoche.
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments